KHP Capital’s Celgene Corp CELG Stock Holding History

KHP Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$70K	Buy	783 +283	+57%	+$25K	0.04%	98
2018 Q2	$40K	Buy	+500	New	+$41.5K	0.03%	121

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KHP Capital's CELG Position: Q3 2018 in Review

KHP Capital increased its Celgene Corp (CELG) stake by 57% in Q3 2018, buying an estimated $25K and bringing the position to 783 shares worth $70K. The position accounts for 0.04% of the portfolio, ranked #98.

KHP Capital first reported a position in CELG in Q2 2018 and has held it in 2 quarters since. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

KHP Capital held 783 shares of Celgene Corp worth $70K as of Q3 2018.
KHP Capital bought 283 Celgene Corp shares in Q3 2018, an estimated $25K.
Celgene Corp made up 0.04% of KHP Capital's portfolio in Q3 2018, its #98 holding.
KHP Capital first reported a position in Celgene Corp in Q2 2018 and has held it in 2 quarters since.
1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on KHP Capital's 13F filing for Q3 2018, filed 8 Nov 2018.